Speech-Language Pathologists in Justice, IL Accepting Medicare
3 Speech-Language Pathologists found. Showing 1 - 3
 Mrs. Marie Laura Tomalis, M.S. CCC-SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7540 S 86th Ave, Justice, IL 60458 Phone: 708-496-8700 |
Kali Marie Martin, MS SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8600 S Roberts Rd, Justice, IL 60458 Phone: 708-430-8295 |
Ranna Halim Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8600 South Roberts Road, Justice, IL 60458 Phone: 708-430-8191 |
News Archive
Pathologic complete response after presurgery chemotherapy increases overall survival for TNBC patients
Patients with stage 2 or stage 3 triple-negative breast cancer (TNBC) who had a pathologic complete response (pCR) after presurgery chemotherapy had increased event-free and overall survival compared with those who had more than minimal residual invasive disease at surgery following presurgery chemotherapy, according to results from the randomized phase II CALGB/Alliance 40603 clinical trial presented at the 2015 San Antonio Breast Cancer Symposium, held Dec. 8-12.
Can you take the COVID-19 and Influenza vaccines on the same day?
Scientists have conducted a substudy within a phase 3 UK trial and have reported the safety, immunogenicity, and efficacy of the NVX-CoV2373 COVID-19 vaccine when co-administered with licensed seasonal influenza vaccines.
Fluctuation in insulin delivery due to pump movement may increase risk of complications in diabetics
Researchers at Sansum Diabetes Research Institute and University of California, Santa Barbara have concluded that changing the height of a conventional insulin pump in relation to its tubing and infusion set can significantly impact expected insulin delivery rates. Such changes can occur during routine daily activities like dressing, sleeping or showering.
MTG Biotherapeutics' MTG-201 granted FDA Orphan Drug Designation for malignant mesothelioma treatment
MTG Biotherapeutics, an immuno-oncology company developing novel therapeutics for the treatment of cancer, today announced that the US Food and Drug Administration has granted Orphan Drug Designation for MTG-201, an advanced biologic therapy targeting Dickkopf-3 gene defects in various cancers, for the treatment of malignant mesothelioma.
› Verified 9 days ago
Speech-Language Pathologists
Podiatrists
Physical Therapists
Occupational Therapists